Anti-Osteoprotegerin 抗体
Anti-Osteoprotegerin antibody
- BOND RX™ Validated
- 了解详情
4
(10 Reviews)
|
(114 Publications)
Rabbit Polyclonal Osteoprotegerin antibody. Suitable for WB, IHC-P, ICC/IF and reacts with Human samples. Cited in 114 publications.
查看别名
OCIF, OPG, TNFRSF11B, Tumor necrosis factor receptor superfamily member 11B, Osteoclastogenesis inhibitory factor, Osteoprotegerin
- IHC-P
Collaborator
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Osteoprotegerin antibody (AB73400)
IHC-P image of Osteoprotegerrin staining on Rat kidney sections using ab73400 (1 : 4000). The sections were deparaffinized and subjected to heat mediated antigen retrieval using citric acid. The sections were blocked using 1% BSA for 10 mins at 21°C. ab73400 was diluted 1 : 4000 in TBS buffer (containing BSA and Azide) and sections were then incubated with ab73400 for 2 hours at 21°C. The secondary antibody used was Biotin conjugated Goat polyclonal to Rabbit IgG (1 : 250).
Image courtesy of Carl Hobbs (Kings College London, United Kingdom)
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Osteoprotegerin antibody (AB73400)
IHC image of Osteoprotegerin staining in Human Normal Kidney FFPE section, performed on a BondTM system using the standard protocol F. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20 mins. The section was then incubated with ab73400, 5µg/ml, for 15 mins at room temperature and detected using an HRP conjugated compact polymer system. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX.
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-Osteoprotegerin antibody (AB73400)
ab73400 staining Osteoprotegerin in HepG2 cells. The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% PBS-Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1%PBS-Tween for 1h. The cells were then incubated overnight at 4°C with ab73400 at 1µg/ml and ab7291, Mouse monoclonal [DM1A] to alpha Tubulin - Loading Control. Cells were then incubated with ab150081, Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (Alexa Fluor® 488), pre-adsorbed at 1/1000 dilution (shown in green) and ab150120, Goat polyclonal Secondary Antibody to Mouse IgG - H&L (Alexa Fluor® 594), pre-adsorbed at 1/1000 dilution (shown in pseudocolour red). Nuclear DNA was labelled with DAPI (shown in blue). Image was acquired with a high-content analyser (Operetta CLS, Perkin Elmer) and a maximum intensity projection of confocal sections is shown.
- WB
Project
Western blot - Anti-Osteoprotegerin antibody (AB73400)
Osteoprotegerin contains a number of potential glycosylation sites (SwissProt) which may explain its migration at a higher molecular weight than predicted.
All lanes:
Western blot - Anti-Osteoprotegerin antibody (ab73400) at 1 µg/mL
Lane 1:
SK N BE (Human neuroblastoma) Whole Cell Lysate at 10 µg
Lane 2:
K562 (Human erythromyeloblastoid leukemia cell line) Whole Cell Lysate at 10 µg
Secondary
All lanes:
Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution
Predicted band size: 46 kDa
Observed band size: 105 kDa,14 kDa,48 kDa
false
Exposure time: 8min
反应性数据
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
OPG inhibits the differentiation and activation of osteoclasts by binding to RANKL preventing its interaction with the receptor RANK on the surface of osteoclast progenitor cells. As part of a non-classical signaling pathway OPG plays a significant role in the regulation of bone remodeling and maintenance by controlling bone resorption. This activity preserves bone density and structure by limiting excessive osteoclastic activity.
Pathways
OPG operates within the RANK/RANKL/OPG signaling axis which is important for bone metabolism. It counteracts the bone-resorption pathway driven by the RANKL-RANK interaction inhibiting osteoclastogenesis. This axis involves interactions with other proteins such as RANK RANKL and TRAIL where TRAIL’s involvement hints towards a broader immune regulation role for OPG.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (114)
Recent publications for all applications. Explore the full list and refine your search
Open life sciences 20:20251126 PubMed40822968
2025
Applications
Unspecified application
Species
Unspecified reactive species
Inflammation : PubMed40447963
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nutrition & diabetes 15:19 PubMed40328755
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic surgery and research 20:403 PubMed40264188
2025
Applications
Unspecified application
Species
Unspecified reactive species
The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology 29:443-454 PubMed40211759
2025
Applications
Unspecified application
Species
Unspecified reactive species
Journal of orthopaedic translation 51:1-12 PubMed39902098
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biomedicines 12: PubMed39595193
2024
Applications
Unspecified application
Species
Unspecified reactive species
The Angle orthodontist 94:566-573 PubMed39230015
2024
Applications
Unspecified application
Species
Unspecified reactive species
Folia histochemica et cytobiologica 62:154-164 PubMed39155743
2024
Applications
Unspecified application
Species
Unspecified reactive species
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 72:419-433 PubMed39054648
2024
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com